2,152
Views
12
CrossRef citations to date
0
Altmetric
Brief Report

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors

, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 592-596 | Received 13 Oct 2021, Accepted 04 Nov 2021, Published online: 20 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 0:0, pages 1-20.
Read now
Alessandro Bonardi, Silvia Bua, Jacob Combs, Carrie Lomelino, Jacob Andring, Sameh Mohamed Osman, Alessandra Toti, Lorenzo Di Cesare Mannelli, Paola Gratteri, Carla Ghelardini, Robert McKenna, Alessio Nocentini & Claudiu T. Supuran. (2022) The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 930-939.
Read now
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, Mariusz Mojzych, Beata Marciniak, Rafał Drozda & Renata Kontek. (2022) Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1278-1298.
Read now
Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Alessio Nocentini, Felipe R. P. Mansoldo & Claudiu T. Supuran. (2022) Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?. Expert Opinion on Drug Discovery 17:10, pages 1147-1158.
Read now
Sridhar Goud Nerella, Priti Singh, Mohammed Arifuddin & Claudiu T Supuran. (2022) Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opinion on Therapeutic Patents 32:8, pages 833-847.
Read now

Articles from other publishers (7)

Toni C. Denner, Niels Heise, Julian Zacharias, Oliver Kraft, Sophie Hoenke & René Csuk. (2023) Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates. Molecules 28:3, pages 1009.
Crossref
Jacob Combs, Murat Bozdag, Lochlin D. Cravey, Anusha Kota, Robert McKenna, Andrea Angeli, Fabrizio Carta & Claudiu T. Supuran. (2023) New Insights into Conformationally Restricted Carbonic Anhydrase Inhibitors. Molecules 28:2, pages 890.
Crossref
Laura Braconi, Elisabetta Teodori, Chiara Riganti, Marcella Coronnello, Alessio Nocentini, Gianluca Bartolucci, Marco Pallecchi, Marialessandra Contino, Dina Manetti, Maria Novella Romanelli, Claudiu T. Supuran & Silvia Dei. (2022) New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells. Journal of Medicinal Chemistry 65:21, pages 14655-14672.
Crossref
Lisa Hiepp, Doris Mayr, Kathrin Gärtner, Elisa Schmoeckel, Frederick Klauschen, Alexander Burges, Sven Mahner, Reinhard Zeidler & Bastian Czogalla. (2022) Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas. PLOS ONE 17:7, pages e0271630.
Crossref
Paul C. McDonald, Shawn C. Chafe, Claudiu T. Supuran & Shoukat Dedhar. (2022) Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers 14:14, pages 3297.
Crossref
Murat Bozdag, Lochlin Cravey, Jacob Combs, Anusha Kota, Robert McKenna, Andrea Angeli, Silvia Selleri, Fabrizio Carta & Claudiu T. Supuran. (2022) Small Molecule Alkoxy Oriented Selectiveness on Human Carbonic Anhydrase II and IX Inhibition. ChemMedChem 17:11.
Crossref
Dimitrios Tsikas. (2022) Editorial. Amino Acids 54:4, pages 481-484.
Crossref